Divi's Laboratories Ltd.
Research Divi's Laboratories Ltd. (DIVISLAB.NS) on Bullrun: market cap INR 2.43T, P/E 83.0, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDIVISLAB.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyINR
- Market capINR 2.43T
- P/E83.0
- Dividend yield0.3%
- Financial periodQ2 2026
- RevenueINR 30.80B
- Net incomeINR 9.02B
- Gross margin68.0%
Valuation Snapshot
latest market cap is INR 2.43T; P/E is 83.0; dividend yield is 0.3%.
Peer valuation comparison
Latest P/E is 82.97x versus a Healthcare sector median of 21.74x (281.6% above).
Latest dividend yield is 0.33% versus a Healthcare sector median of 2.4% (86.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 2.43T | 83.0 | 0.3% | 30 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 30 INR, yield 0.3%.
About Divi's Laboratories Ltd.
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Divi's Laboratories Ltd.'s market cap?
Divi's Laboratories Ltd.'s market capitalization is INR 2.43T.
What is Divi's Laboratories Ltd.'s P/E ratio?
Divi's Laboratories Ltd.'s price-to-earnings (P/E) ratio is 83.0.
Does Divi's Laboratories Ltd. pay a dividend?
Divi's Laboratories Ltd. has a dividend yield of 0.3%.
What does Divi's Laboratories Ltd. do?
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products.